COGNITIVE FUNCTIONS IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER PATIENTS: A COMPARATIVE STUDY

被引:0
|
作者
Mondragon-Maya, Alejandra [1 ]
Ramos-Mastache, Daniela [1 ]
Yanez-Tellez, Guillermina [1 ]
Saracco-Alvarez, Ricardo [2 ]
机构
[1] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico
[2] Inst Nacl Psiquiatria Ramon de la Fuente, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
SA32
引用
收藏
页码:S124 / S125
页数:2
相关论文
共 50 条
  • [1] The comparison of Cognitive Functions in Schizophrenia and Schizoaffective Disorder
    Varma, Gulfizar Sozeri
    Ozdel, Osman
    Karadag, Filiz
    Tumkaya, Selim
    Kalayci, Demet
    Kaya, Simge
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2011, 24 (03): : 175 - 181
  • [2] Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
    Smith, Robert C.
    Lindenmayer, Jean-Pierre
    Davis, John M.
    Cornwell, James
    Noth, Kathryn
    Gupta, Sanjay
    Sershen, Henry
    Lajtha, Abel
    SCHIZOPHRENIA RESEARCH, 2009, 110 (1-3) : 149 - 155
  • [3] Assessment of Cognitive Functions Among Remitted Patients of Schizophrenia and Bipolar Disorder: A Comparative Study
    Selvameenatchi, R.
    Jetty, Ramya Rachel
    Kaki, Aruna
    Gunapalli, Suresh Kumar
    Kumar, N. Prasanna
    Saravanan, R. Arul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [4] Impact of Anticholinergic Burden on Cognitive Functions in Individuals with Bipolar Disorder, Schizoaffective Disorder, and Schizophrenia
    Erdogan, Nilgun Oktar
    Yucens, Bengu
    Tumkaya, Selim
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2025, 23 (01) : 76 - 85
  • [5] Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder
    Harvey, P
    Meltzer, H
    Green, M
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 123S - 123S
  • [6] Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder
    Mahmoud, R
    Harvey, PD
    Meltzer, HY
    Green, MF
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 236 - 237
  • [7] Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder
    Elie, D.
    Poirier, M.
    Chianetta, J. M.
    Durand, M.
    Gregoire, C. A.
    Grignon, S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 1037 - 1044
  • [8] Cognitive functioning and insight in schizophrenia and in schizoaffective disorder
    Birindelli, Nadia
    Montemagni, Cristiana
    Crivelli, Barbara
    Bava, Irene
    Mancini, Irene
    Rocca, Paola
    RIVISTA DI PSICHIATRIA, 2014, 49 (02) : 77 - 83
  • [9] Characterisation of cognitive functioning in schizophrenia and schizoaffective disorder
    Dorofeikova, M.
    Petrova, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S330 - S331
  • [10] Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?
    Lewandowski, Kathryn E.
    Eack, Shaun M.
    Hogarty, Susan S.
    Greenwald, Deborah P.
    Keshavan, Matcheri S.
    SCHIZOPHRENIA RESEARCH, 2011, 125 (2-3) : 291 - 294